scholarly article | Q13442814 |
P50 | author | James D Crapo | Q89513460 |
Richard Casaburi | Q89536949 | ||
Craig P Hersh | Q89639965 | ||
Sharon M Lutz | Q90289666 | ||
George R Washko | Q91328029 | ||
Stephanie A. Santorico | Q91339706 | ||
Barry Make | Q91363352 | ||
R. Graham Barr | Q110621772 | ||
Peter J Castaldi | Q41046861 | ||
Frank Sciurba | Q43092714 | ||
Marilyn G. Foreman | Q54145791 | ||
Douglas Curran-Everett | Q56550187 | ||
Michael H Cho | Q63385219 | ||
Elizabeth A Regan | Q77671745 | ||
Dawn L DeMeo | Q88189936 | ||
David A Lynch | Q88676277 | ||
MeiLan K Han | Q89513454 | ||
John E Hokanson | Q89513456 | ||
Edwin K Silverman | Q89513458 | ||
P2093 | author name string | Russ P Bowler | |
Gerald J Criner | |||
James Ross | |||
Yale Chang | |||
Jennifer Dy | |||
Greg L Kinney | |||
Andre Williams | |||
Xavier Soler | |||
Edwin van Beek | |||
Joseph W Ramsdell | |||
Steven I Rennard | |||
P2860 | cites work | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 |
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema | Q28205534 | ||
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
A genome-wide association study of pulmonary function measures in the Framingham Heart Study | Q33419839 | ||
Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes | Q33462211 | ||
Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation | Q33541285 | ||
Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
Genetic epidemiology of COPD (COPDGene) study design | Q34074731 | ||
Characterisation of COPD heterogeneity in the ECLIPSE cohort | Q34149510 | ||
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease | Q34535065 | ||
The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago | Q34696714 | ||
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. | Q35816887 | ||
Sex differences in severe pulmonary emphysema | Q36013675 | ||
A pathologist's view of airway obstruction in chronic obstructive pulmonary disease | Q42325639 | ||
The many "small COPDs": COPD should be an orphan disease | Q44243499 | ||
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes | Q44406271 | ||
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses | Q44705401 | ||
The GOLD classification has advanced understanding of COPD. | Q47950295 | ||
CLINICAL TYPES OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN LONDON AND IN CHICAGO. A STUDY OF ONE HUNDRED PATIENTS | Q53042242 | ||
The EvA study: aims and strategy. | Q53169870 | ||
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. | Q53409072 | ||
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 | ||
Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography | Q79276527 | ||
Identification of a predominant COPD phenotype in clinical practice | Q80629727 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cluster analysis | Q622825 |
P304 | page(s) | 415-422 | |
P577 | publication date | 2014-02-21 | |
P1433 | published in | Thorax | Q7796158 |
P1476 | title | Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema | |
P478 | volume | 69 |
Q39004803 | A Bayesian Nonparametric Model for Disease Subtyping: Application to Emphysema Phenotypes. |
Q47170520 | A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups |
Q41112661 | A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease. |
Q33764829 | Automatic tissue characterization of air trapping in chest radiographs using deep neural networks. |
Q35805903 | Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease |
Q38563906 | Can metabotyping help deliver the promise of personalised nutrition? |
Q26777324 | Candidate genes for COPD: current evidence and research |
Q55341285 | Clean Fuels to Reduce Household Air Pollution and Improve Health. Still Hoping to Answer Why and How. |
Q92669313 | Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD |
Q41522898 | Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients |
Q38604667 | Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD. |
Q36907742 | Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. |
Q90083689 | Defining severe obstructive lung disease in the biologic era: an endotype-based approach |
Q38715004 | Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts |
Q57092162 | Environmental exposures and systemic hypertension are risk factors for decline in lung function |
Q28383674 | Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene |
Q51615224 | Evaluation of the visit frequency and the use of questionnaires and indices for COPD: a national survey from the On-Sint study. |
Q91908143 | Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations |
Q39351123 | Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution |
Q41493817 | Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis |
Q38604624 | Identifying Patients With COPD at High Risk of Readmission |
Q64101834 | Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records |
Q57282434 | Imaging Advances in Chronic Obstructive Pulmonary Disease: Insights from COPDGene |
Q53028581 | Imaging biomarkers in the clinic. |
Q58725160 | Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) |
Q91895197 | Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS) |
Q34232677 | Integrative genomics of chronic obstructive pulmonary disease. |
Q45945497 | Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression. |
Q47748333 | Metabotyping for the development of tailored dietary advice solutions in a European population: the Food4Me study |
Q92533356 | Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients |
Q42591123 | NHLBI Strategic Visioning: setting an agenda together for the NHLBI of 2025. |
Q43216278 | NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. |
Q86841014 | National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025 |
Q35637182 | Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation |
Q34436462 | Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus |
Q89513955 | Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach |
Q92044310 | Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies |
Q27027259 | Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014 |
Q64086915 | RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD |
Q35565173 | Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk |
Q38827548 | Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions |
Q99609704 | Somatotypes trajectories during adulthood and their association with COPD phenotypes |
Q38604607 | Subtyping Chronic Obstructive Pulmonary Disease Using Peripheral Blood Proteomics |
Q47745623 | The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study |
Q26800388 | The short and long telomere syndromes: paired paradigms for molecular medicine |
Q51034019 | Use of metabotyping for the delivery of personalised nutrition. |
Q38376166 | Year in review 2014. Paediatric and adult clinical studies |
Search more.